Welcome to Nivagen Pharmaceuticals
Nivagen is engaged in the development, acquisition and sales of generic prescription drugs and over the counter products for the North American market. Our vision is to deliver high quality products at affordable prices by leveraging global partnerships with the best FDA approved manufacturing facilities across the world.
Acquisition and Licensing Model
The US generic market is large and growing. The market is complex and fragmented and requires a variety of infrastructures to reach all major channels and segments
Every business has its individual core strengths. One of Nivagen’s core strengths is the ability of our sales team to launch new generic products in the US market.
Product Development / Co-Development Model
Nivagen's business model is to identify and utilize the world`s best and economical CROs and CRAMs to develop and manufacture niche generic and OTC products.
Come Meet With Us
Nivagen will be at the following events in 2021-2022:
CPhI North America 2022 – TBT
CPhI Worldwide 2022 – TBT
ECRM Retail Pharmacy – Generic Rx EPPS 2022– February 28-March 3, in Dallas, Texas
DCAT Week 2022– March 19-23, in New York City, New York
NACDS Total Store Expo 2022 – April 23-26, Palm Beach, Florida